City

Chengdu (1)

Condition

Diffuse Large B Cell Lymphoma,DLBCL (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Chengdu Zenitar Biomedical Technology Co., Ltd (1)

Collaborator

Intervention

pm 11.2 mg/m2 (1)

pm 8.4 mg/m2 (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

diffuse large b cell lymphoma，dlbcl

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Diffuse Large B Cell Lymphoma,DLBCL Trial in Chengdu (PM 8.4 mg/m2, PM 11.2 mg/m2)

Recruiting

Diffuse Large B Cell Lymphoma，DLBCL

PM 8.4 mg/m2
PM 11.2 mg/m2

Chengdu, Sichuan, China

West China Hospital Sichuan University

Jan 15, 2023